# info@crystallizationsummit.com
English

Office Address

  • info@crystallizationsummit.com
  • Phone: +1 732-978-0828

Pinterest

Social List

News Right Sidebar

pcs2023-speakers , pcs2023 , session-1-enable-greener-ds-synthetic-route

Dr. Scott Shultz, Merck & Co.

August 18, 2023
pcs2023-speakers , pcs2023 , session-2-enable-desired-ds-quality-attributes

Dr. Haitao Zhang, Sumitomo Pharma America

August 18, 2023
pcs2023-abstracts , pcs2023 , session-1-enable-greener-ds-synthetic-route

Development of a scalable atroposelective process to MRTX1719-an inhibitor of the PRMT5*MTA complex

August 16, 2023
pcs2023-abstracts , pcs2023 , session-2-enable-desired-ds-quality-attributes

Drug Substance Physical Property Control in the Process of Crystallization

August 16, 2023
pcs2023-abstracts , pcs2023 , session-1-enable-greener-ds-synthetic-route

Enabling efficient synthetic route selection by robust purification in crystallization

August 16, 2023
pcs2023-speakers , pcs2023 , session-1-enable-greener-ds-synthetic-route

Dr. Fredrik Nordstrom

August 16, 2023
pcs2022-speakers , panel-discussions , pcs2022

Dr. Luca Iuzzolino, Merck & Co.

September 29, 2022
pcs2022-speakers , pcs2022pd-03 , pcs2022

Dr. Vivian Bi, Aclaris Therapeutics

September 26, 2022
pcs2022pd-01 , pcs2022-speakers , pcs2022

Dr. Veeran Gowda Kadajji, J-STAR Research

September 26, 2022
pcs2022-speakers , cmc-strategy-workshop , pcs2022

Dr. Qi Gao, J-Star Research

September 26, 2022
RSS
Follow by Email
Facebook
Twitter
LinkedIn
Share